Precision Radiation Oncology, EarlyView.
Valeria Conte, Anna Bianchi, Anna Selva
europepmc +4 more sources
Multi-fidelity Monte Carlo fusion for BNCT dose calculation using a dual-branch network. [PDF]
Abstract Background Boron neutron capture therapy (BNCT) is a binary radiotherapy that selectively kills tumor cells. Its clinical implementation relies on Monte Carlo (MC)‐based treatment planning systems, which are time‐consuming and limit clinical workflow efficiency.
Li L +7 more
europepmc +2 more sources
A coarse-to-fine framework combining deep learning and Monte Carlo for BNCT patient position optimization toward inverse planning. [PDF]
Abstract Background Boron Neutron Capture Therapy (BNCT) utilizes high linear energy transfer (LET) charged particles from the 10B(n,α)7Li reaction to selectively destroy tumor cells. Unlike conventional radiation therapy, BNCT facilities rely on fixed beam ports, making patient positioning critical in treatment planning.
Na Y +5 more
europepmc +2 more sources
Safety, efficacy, pharmacokinetics, and mechanisms of novel <sup>10</sup>B-boronophenylalanine combined with a radio-frequency quadrupole accelerator in boron neutron capture therapy: A preclinical study in head and neck squamous cell carcinoma. [PDF]
This study demonstrates that the novel 10B‐BPA‐based BNCT system, combined with an RFQ accelerator, effectively targets head and neck squamous cell carcinoma. It induces tumor regression safely and efficiently by triggering DNA damage and activating the ROS/HIF‐1α/NF‐κB pathway, leading to caspase‐3‐mediated apoptosis.
Zhang Z +13 more
europepmc +2 more sources
Advances in boron neutron capture therapy (BNCT) at kyoto university - From reactor-based BNCT to accelerator-based BNCT [PDF]
At the Kyoto University Research Reactor Institute (KURRI), a clinical study of boron neutron capture therapy (BNCT) using a neutron irradiation facility installed at the research nuclear reactor has been regularly performed since February 1990. As of November 2014, 510 clinical irradiations were carried out using the reactor-based system.
Sakurai, Yoshinori +12 more
openaire +3 more sources
Quantification of <sup>10</sup>B and <sup>11</sup>B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT). [PDF]
ABSTRACT Boron neutron capture therapy (BNCT) is a targeted radiotherapy that exploits the selective accumulation of the 10B isotope within tumors, followed by irradiation with low‐energy neutrons to induce high linear energy transfer particles with short path lengths, resulting in localized tumor cell destruction while sparing surrounding healthy ...
Selg C, Sauerwein WAG, Hey-Hawkins E.
europepmc +2 more sources
Transporter-Associated Therapeutic Efficacy of an SMVT-Targeted Boron Carrier in Boron Neutron Capture Therapy. [PDF]
The transporter‐associated BNCT strategy using BBCIP with or without BPA according to tumor transporter characteristics. BPA showed greater efficacy in LAT1‐dominant F98 glioma, whereas BBCIP was more effective in SMVT‐high CRL1666 tumors, suggesting the potential utility of transporter‐based boron carrier selection in BNCT.
Eza K +15 more
europepmc +2 more sources
Boron neutron capture therapy combined with immunotherapy: insights from radiotherapy, BNCT-specific evidence, and future directions [PDF]
Boron neutron capture therapy (BNCT), a precision radiotherapy modality, has shown significant promise in targeted cancer treatment. Like conventional radiotherapy, the development of radioresistance hinders the efficacy of BNCT.
Zeyuan Li +10 more
doaj +2 more sources
Biomimetic Macrophage Cell Membrane-Based Nanoparticles for Effective Treatment of Glioblastoma Through Boron Neutron Capture Therapy Combined With Immunotherapy. [PDF]
ABSTRACT Glioblastoma multiforme (GBM) remains largely incurable due to the blood‐brain barrier (BBB) and immunosuppressive microenvironment. While boron neutron capture therapy (BNCT) selectively eradicates tumor cells via 10B(n, α)‐7Li reactions, its clinical potential in GBM is unrealized because of the suboptimal pharmacokinetics of conventional ...
Chen J +22 more
europepmc +2 more sources
Combined BNCT and PET for theranostics
Abstract This short review summarizes the issue of boron distribution monitoring in boron neutron capture therapy (BNCT), which remains a serious drawback of this powerful oncological treatment. Here we present the monitoring methods that are presently used with particular emphasis on the positron emission tomography (PET) which has the ...
Silarski, Michał +2 more
openaire +4 more sources

